0000899243-20-017277.txt : 20200619
0000899243-20-017277.hdr.sgml : 20200619
20200619170658
ACCESSION NUMBER: 0000899243-20-017277
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200617
FILED AS OF DATE: 20200619
DATE AS OF CHANGE: 20200619
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kallenbach Charles
CENTRAL INDEX KEY: 0001309021
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38977
FILM NUMBER: 20976440
MAIL ADDRESS:
STREET 1: 1100 CASSATT ROAD
STREET 2: C/O SUNCOM WIRELESS
CITY: BERWYN
STATE: PA
ZIP: 19312
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phreesia, Inc.
CENTRAL INDEX KEY: 0001412408
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 432 PARK AVENUE S.
STREET 2: 12TH FLOOR
CITY: New York
STATE: NY
ZIP: 10016
BUSINESS PHONE: 646-747-9959
MAIL ADDRESS:
STREET 1: 432 PARK AVENUE S.
STREET 2: 12TH FLOOR
CITY: New York
STATE: NY
ZIP: 10016
FORMER COMPANY:
FORMER CONFORMED NAME: Phreesia Inc
DATE OF NAME CHANGE: 20070914
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-17
0
0001412408
Phreesia, Inc.
PHR
0001309021
Kallenbach Charles
C/O PHREESIA, INC.
432 PARK AVENUE SOUTH, 12TH FLOOR
NEW YORK
NY
10016
0
1
0
0
General Counsel & Secretary
Common Stock
2020-06-17
4
M
0
2500
2.55
A
41650
D
Common Stock
2020-06-17
4
S
0
2500
29.2581
D
39150
D
Stock Option (Right to Buy)
2.55
2020-06-17
4
M
0
2500
0.00
D
2026-10-16
Common Stock
2500
146785
D
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.91 to $29.48 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
25% of this option vested and became exercisable on October 17, 2017, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
/s/ Charles Kallenbach
2020-06-19